Federal Policy
DEA Moves to Restrict Synthetic Kratom Extract 7-OH
Federal authorities and lawmakers are increasing scrutiny of concentrated kratom extracts, including a compound known as 7-OH, sold over the counter in most states as the so-called "gas station opioid." The DEA earlier this year announced plans to temporarily ban products containing elevated concentrations of the substance, citing public health risks. The products are currently unregulated at the federal level in most jurisdictions, raising concerns about potency, labeling, and abuse potential. Increased federal attention signals possible scheduling action or new restrictions affecting product availability nationwide.
Why it mattersBehavioral health providers and state Medicaid agencies should anticipate new substance-use treatment and coverage questions if federal scheduling action restricts access to these unregulated opioid-like products.
Also covered by:thehill.com